Compare REBN & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REBN | PAVM |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5M | 41.1M |
| IPO Year | 2017 | 2015 |
| Metric | REBN | PAVM |
|---|---|---|
| Price | $1.15 | $4.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | ★ 123.3K | 22.8K |
| Earning Date | 04-22-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,094,628.00 | $3,000,000.00 |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.54 | 20.00 |
| 52 Week Low | $0.67 | $0.21 |
| 52 Week High | $2.95 | $28.44 |
| Indicator | REBN | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 55.07 | N/A |
| Support Level | $0.91 | N/A |
| Resistance Level | $2.02 | N/A |
| Average True Range (ATR) | 0.14 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 87.50 | 0.00 |
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is a company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in two reportable segments: Reborn Coffee, which includes both the wholesale and retail sales of coffee, water, and other beverages, and Reborn Logistics, which provides freight forwarding services.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.